Email updates

Keep up to date with the latest news and content from BMC Pharmacology and Toxicology and BioMed Central.

Open Access Pre-publication history

No changes of cholesterol levels with a commercially available glucosamine product in patients treated with lipid lowering drugs: a controlled, randomised, open cross-over trial

Robert Eggertsen*, Åke Andreasson and Lennart Andrén

BMC Pharmacology and Toxicology 2012, 13:10  doi:10.1186/2050-6511-13-10

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 21 Sep 2011
Resubmission - Version 2 Manuscript Author's comment 06 Oct 2011
Resubmission - Version 3 Manuscript Author's comment 03 Nov 2011
Reviewer's Report Andrew Tershakovec 19 Jan 2012
Reviewer's Report Angel-Luis García-Otín 23 May 2012
Resubmission - Version 4 Manuscript Author's comment 20 Jun 2012
Reviewer's Report Angel-Luis García-Otín 07 Jul 2012
Reviewer's Report Andrew Tershakovec 26 Jul 2012
Resubmission - Version 5 Manuscript Author's comment 03 Aug 2012
Editorial acceptance 05 Oct 2012
Published 10 Oct 2012